Sell Biocon; target of Rs 330: Motilal Oswal News News / News 6 years ago 437 Views comments Motilal Oswal is bullish on Biocon has recommended Sell rating on the stock with a target price of Rs 330 in its research report dated July 28, 2017 Read more
News Aurobindo Pharma in talks to buy the Russian business of Shreya Life Sciences News / News - 6 years ago
News SBI refuses terms of JSW#39;s offer to buy Monnet Ispat; next hearing on Monday News / News - 6 years ago
News Congress leader P Chidambaram ribs RBI for buying note counting machines after 8 months, Mudra scheme News / News - 6 years ago
Comments